{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:53:57Z","timestamp":1791179637797,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>AKNA, an AT-hook transcription factor, plays a critical role in cancer development. However, its prognostic value and biological function in endometrial cancer (EC) remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To systematically investigate AKNA in EC, we integrated multi-omics data (The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and single-cell transcriptomics), dual independent clinical cohorts (TCGA-UCEC dataset and two institutional cohorts), and\n                      <jats:italic>in vitro<\/jats:italic>\n                      \/\n                      <jats:italic>in vivo<\/jats:italic>\n                      experimental models. Immunohistochemistry, RT-qPCR and Western blotting were used for expression validation. Functional assays, including lentiviral-mediated AKNA knockdown\/overexpression, CCK-8, scratch-wound, Transwell, flow cytometry, and colony formation assays were conducted to assess the effects of AKNA modulation on proliferation, migration, invasion, epithelial-mesenchymal transition, chemosensitivity and macrophage polarization. Mechanistically, chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq), ChIP-qPCR, and dual-luciferase reporter assays were employed to define the transcriptional regulation of stimulator of interferon genes (STING) by AKNA. A prognostic nomogram integrating AKNA expression with clinicopathological features was developed and externally validated in independent cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AKNA was significantly downregulated in EC tissues compared with normal endometrium, which was associated with advanced International Federation of Gynecology and Obstetrics stage, aggressive histological subtypes, and poor prognosis. AKNA knockdown promoted EC cell proliferation, migration, invasion, and epithelial-mesenchymal transition, while enhancing M2 macrophage polarization and reducing sensitivity to paclitaxel and potentially compromising anti-tumor innate immunity. Conversely, AKNA overexpression or STING activation by cyclic GMP\u2013AMP reversed these malignant phenotypes. Mechanistically, AKNA directly bound to the STING promoter and transcriptionally activated STING, thereby inducing TANK-binding kinase 1 and interferon regulatory factor 3 phosphorylation. The nomogram combining AKNA with clinicopathological features demonstrated high accuracy in predicting EC recurrence and outperformed single-variable models in both training and validation cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AKNA deficiency promotes EC progression by transcriptionally suppressing STING and driving M2 macrophage polarization. AKNA serves as a robust prognostic biomarker and predictive indicator for chemotherapy and innate immune modulation, offering a promising therapeutic target for precision treatment of EC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1905624","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:31:39Z","timestamp":1791178299000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["AKNA serves as a prognostic biomarker and restrains endometrial cancer progression via STING activation and macrophage reprogramming"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuan","family":"Tu","sequence":"first","affiliation":[{"name":"Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingya","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Chongqing University Qianjiang Hospital (Qianjiang Central Hospital of Chongqing)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfan","family":"Tian","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanling","family":"Shi","sequence":"additional","affiliation":[{"name":"International Medical College, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Yu","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women and Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Peng","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HangKun","family":"Yu","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yuan","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102790","article-title":"Locally advanced and metastatic endometrial cancer: Current and emerging therapies","volume":"129","author":"Salmon","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1763091","article-title":"Does immunotherapy hold great promise in endometrial cancer care","volume":"17","author":"Braszka","year":"2026","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12967-025-07497-w","article-title":"mRNA-based immunotherapy platform targeting endometrial cancer","volume":"24","author":"Freyberg","year":"2025","journal-title":"J Transl Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3390\/biom11111709","article-title":"Functional role of AKNA: A scoping review","volume":"11","author":"Ram\u00edrez-Gonz\u00e1lez","year":"2021","journal-title":"Biomolecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gene.2014.60","article-title":"Cervical cancer-associated promoter polymorphism affects akna expression levels","volume":"16","author":"Mart\u00ednez-Nava","year":"2015","journal-title":"Genes Immun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/cancers10120521","article-title":"The Human Papillomavirus (HPV) E6 oncoprotein regulates CD40 expression via the AT-hook transcription factor AKNA","volume":"10","author":"Manzo-Merino","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/cimb47020078","article-title":"Identification of AKNA gene and its role for genetic susceptibility in epithelial ovarian cancer","volume":"47","author":"Suryandari","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0962-4","article-title":"The centrosome protein AKNA regulates neurogenesis via microtubule organization","volume":"567","author":"Camargo Ortega","year":"2019","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6726759","article-title":"AKNA is a potential prognostic biomarker in gastric cancer and function as a tumor suppressor by modulating EMT-related pathways","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: An integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","author":"Gy\u0151rffy","year":"2024","journal-title":"Innovation (Camb)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky311","article-title":"GeneMANIA update 2018","volume":"46","author":"Franz","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1738596","article-title":"The prognostic significance of JAML and its role in remodeling the immune microenvironment via the cGAS-STING pathway in endometrial cancer","volume":"17","author":"Tian","year":"2026","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.906420","article-title":"Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-18663-1","article-title":"Nomogram based on pan-immune inflammation value and clinicopathological parameters for predicting the recurrence of endometrial cancer and providing postoperative prognostic management","volume":"33","author":"Long","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1559278","article-title":"Prognostic significance and immune infiltration analysis of HMGA2 in endometrial cancer","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1338908","article-title":"The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer","volume":"14","author":"Jiang","year":"2024","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335014","article-title":"Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells","volume":"75","author":"Cui","year":"2025","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41698-025-01169-0","article-title":"Siglec-14-LGALS3BP glycoimmune axis shapes tumor-associated macrophage polarization and confers poor outcome in colorectal cancer","volume":"9","author":"Lin","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"016112","DOI":"10.1063\/5.0250173","article-title":"PCBP2 promotes immune evasion via cGAS-STING pathway in biochemical recurrence of prostate cancer","volume":"9","author":"Zhou","year":"2025","journal-title":"APL Bioeng"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S329921","article-title":"Different induction of PD-L1 (CD274) and PD-1 (CD279) expression in THP-1-differentiated types 1 and 2 macrophages","volume":"14","author":"Lai","year":"2021","journal-title":"J Inflammation Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s11658-024-00583-9","article-title":"Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9\/GSK3\u03b2\/\u03b2-catenin signaling","volume":"29","author":"Lin","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13550-025-01235-5","article-title":"Evaluation of early chemotherapy response by combining static- and dynamic [(18)F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models","volume":"15","author":"Espedal","year":"2025","journal-title":"EJNMMI Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2022.2054105","article-title":"STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer","volume":"11","author":"Da","year":"2022","journal-title":"Oncoimmunology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/35066602","article-title":"Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA","volume":"410","author":"Siddiqa","year":"2001","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS\u2013STING pathway in cancer immunity: Mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1523518","article-title":"Predicting immunotherapy efficacy in endometrial cancer: Focus on the tumor microenvironment","volume":"15","author":"Tashireva","year":"2024","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S201177","article-title":"The relevance between the immune response-related gene module and clinical traits in head and neck squamous cell carcinoma","volume":"11","author":"Song","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.855387","article-title":"Identification of an immune classification and prognostic genes for lung adenocarcinoma based on immune cell signatures","volume":"9","author":"Deng","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.3390\/ijms24044212","article-title":"Critical role of the transcription factor AKNA in T-cell activation: An integrative bioinformatics approach","volume":"24","author":"Ram\u00edrez-Gonz\u00e1lez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00839-6","article-title":"cGAS and cancer therapy: A double-edged sword","volume":"43","author":"Du","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1186\/s12967-025-06843-2","article-title":"The cGAS-STING pathway: A dual regulator of immune response in cancer and therapeutic implications","volume":"23","author":"Huang","year":"2025","journal-title":"J Transl Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","article-title":"Structures and mechanisms in the cGAS-STING innate immunity pathway","volume":"53","author":"Zhang","year":"2020","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: Precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.3390\/cancers14194718","article-title":"Histone deacetylase 3 governs \u03b2-estradiol-ER\u03b1-involved endometrial tumorigenesis via inhibition of STING transcription","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"494","DOI":"10.4049\/jimmunol.2400123","article-title":"HIF-1 transcriptionally regulates basal expression of STING to maintain cellular innate immunity","volume":"213","author":"Gao","year":"2024","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121336","article-title":"NF-\u03baB regulates the expression of STING via alternative promoter usage","volume":"314","author":"Chen","year":"2023","journal-title":"Life Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201439366","article-title":"Positive feedback regulation of type I interferon by the interferon-stimulated gene STING","volume":"16","author":"Ma","year":"2015","journal-title":"EMBO Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.012","article-title":"DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity","volume":"42","author":"H\u00e4rtlova","year":"2015","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e2100225118","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-\u03baB that mediate immune defense against tumors and viral infections","volume":"118","author":"Yum","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41419-025-07960-y","article-title":"Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS\/STING signaling in gastric cancer cells","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41419-023-05655-w","article-title":"MLKL signaling regulates macrophage polarization in acute pancreatitis through CXCL10","volume":"14","author":"Peng","year":"2023","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.061120","article-title":"Drug discovery in advanced and recurrent endometrial cancer: Recent advances","volume":"33","author":"Francoeur","year":"2025","journal-title":"Oncol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080978","article-title":"Advances in the management of endometrial cancer","volume":"388","author":"Corr","year":"2025","journal-title":"Bmj"},{"key":"B55","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41420-022-01256-2","article-title":"Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS\/STING in non-small cell lung cancer","volume":"8","author":"Han","year":"2022","journal-title":"Cell Death Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1905624\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:31:40Z","timestamp":1791178300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1905624\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2026.1905624"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1905624","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1905624"}}